Therapeutic Areas | Belgium
Our Therapeutic Areas
At Takeda Belgium, we are dedicated to addressing the unmet medical needs of patients through an extensive range of therapeutic areas. Our commitment to innovation and patient care drives us to deliver life-transforming treatments and vaccines across various medical fields.
Discover more about the therapeutic areas we focus on in Belgium.
Understanding and addressing life-limiting gastrointestinal and inflammatory diseases
Our focus on gastrointestinal and inflammatory diseases includes treatments for conditions such as Ulcerative Colitis, Crohn's Disease, and Short Bowel Syndrome. We strive to improve the quality of life for patients suffering from these chronic conditions.
Aspiring to cure cancer, with inspiration from patients and innovation from everywhere
Takeda's oncology portfolio focuses on providing innovative treatments for various cancers, including blood cancers like Multiple Myeloma and Lymphoma, and Non-Small Cell Lung Cancer. We are dedicated to advancing cancer care and offering hope to patients through cutting-edge therapies.
Working to transform treatments in immunology, hematology, metabolic and lysosomal storage disorders
Takeda is a leader in the treatment of rare diseases, such as Hunter Syndrome, Type 1 Gaucher Disease, Fabry Disease, Hereditary Angioedema (HAE), Hemophilia A, and Acquired Hemophilia. Our dedication to rare diseases extends to the use of AI in early detection and partnerships with healthcare professionals to enhance patient outcomes.
Striving to improve the lives of patients with rare and complex chronic diseases through innovation in plasma
Plasma-Derived Therapies (PDTs) are used for treating a variety of rare, often chronic, and sometimes life-threatening conditions. These include immune deficiencies, bleeding disorders, and autoimmune diseases.
Driving medical innovation for patients with neurological diseases
In the field of neuroscience, we are committed to addressing significant unmet needs, such as Attention-Deficit Hyperactivity Disorder (ADHD) and other neurological conditions.
Aspiring to transform the treatment of infections in transplant patients and provide them personalized care.
For every transplant to carry the best possible chance of success, transplant teams must be resourced and supported to deliver great care. From preparation, to transplant, and follow-up care. As part of this, efforts are made to prevent and treat common viral infections to which transplant patients are particularly vulnerable, such as cytomegalovirus (CMV).
Addressing unmet global health needs through vaccine development against infectious diseases
Our vaccine division is at the forefront of preventing infectious diseases. We are actively involved in developing and distributing vaccines for diseases, contributing to global health and safety.
For more info check here: www.infodengue.be
